Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by Novavax, Inc. on June 17, 2010. The filing details the outcomes of shareholder votes regarding the election of directors and the ratification of the independent auditor.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and does not contain financial performance data.
Material Changes
No material financial changes are reported in this filing. The document serves to disclose the results of the shareholder vote rather than operational or financial shifts.
Corporate Governance and Voting Results
Shareholders elected three Class III directors to serve until the 2013 Annual Meeting and ratified the selection of Grant Thornton LLP as the independent auditor for the fiscal year ending December 31, 2010.
Director Election Results
| Director | For | Withheld | Broker Non-Votes |
|---|---|---|---|
| Stanley C. Erck | 42,904,038 | 6,093,849 | 32,186,736 |
| Michael A. McManus, Jr., J.D. | 43,620,884 | 5,377,003 | 32,186,736 |
| James F. Young, Ph.D. | 47,991,954 | 1,005,933 | 32,186,736 |
Auditor Ratification Results
| Proposal | For | Against | Abstain |
|---|---|---|---|
| Ratification of Independent Auditor (Grant Thornton LLP) | 80,636,168 | 416,890 | 131,565 |
Investor Verification Checklist
- Verify the tenure of the newly elected Class III directors (Stanley C. Erck, Michael A. McManus, Jr., and James F. Young) through the 2013 Annual Meeting.
- Confirm the appointment of Grant Thornton LLP as the independent auditor for the fiscal year ending December 31, 2010.
- Note the significant number of broker non-votes (32,186,736) recorded for the director elections, which may indicate shares held in street name where brokers lacked discretionary voting authority.